Prevention & lipids

Does Adiponectin Inform Cardiovascular Risk in Older Adults??: The ARIC Study

JACC AdvPublished prospective cohort study

Main finding · Incident HFResult — go to the resultHazard ratio 1.91 per natural-log unit increase 95% CI 1.49–2.44

Authors' conclusion

Elevated adiponectin and NT-proBNP in older adults are associated with increased risk for HF and CVD death beyond traditional risk factors.

Study context

Population
Atherosclerosis Risk in Communities participants without baseline cardiovascular disease (CVD) at visit 5, mean age 75participants without baseline CVD at visit 5
Participants
4,729 participants
Exposure
Adiponectin and adiponectin/NT-proBNP category associations with incident CVD events
Outcome
Incident HF
Follow-up
Median 5.5 years

Main finding

As reported in the abstract

Hazard ratio

1.91 per natural-log unit increase

95% CI 1.49–2.44

Higher adiponectin
HR 1.91 per natural-log unit increase (95% CI 1.49–2.44)

Per natural-log unit increase, as printed

Observational data: associations, not effects.

Further findings

OutcomeEstimate
CVD death · median follow-up of 5.5 yearsHR 1.67 per natural-log unit increase (95% CI 1.19–2.32)
HF and CVD death by adiponectin/NT-proBNP categoryA+/N+ vs A+/N- · HFHR 5.41 (95% CI 2.72–10.78)
HF and CVD death by adiponectin/NT-proBNP categoryA+/N+ vs A+/N- · CVD deathHR 3.50 (95% CI 1.48–8.24)
HF and CVD death by adiponectin/NT-proBNP categoryA-/N+ vs A+/N- · HFHR 2.84 (95% CI 1.41–5.72)

Heart failure with preserved ejection fraction

No significant association between adiponectin and heart failure with preserved ejection fraction after adjusting for NT-proBNP

HF and CVD death by adiponectin/NT-proBNP category

A-/N- had no increased event risk

Metabolomic signature of A+/N+

Similar to NT-proBNP's
88%
Acylcarnitine species consistent with incomplete beta-oxidation; top-associated metabolites were significantly associated with HF and CVD death

Original publication

Does Adiponectin Inform Cardiovascular Risk in Older Adults??: The ARIC Study. JACC Adv. Published 20 February 2025. doi:10.1016/j.jacadv.2025.101625

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.